Citius Pharmaceuticals, Inc. (CTXR) Stock Forecast
Data as of May 9, 2026Healthcare · Current price $0.64 (-2.90%)
Consensus Target
—
Upside
—
Analysts
2
Rating
Buy(2.00)
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
Consensus
Buy
Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
No analyst price targets available.
CTXR vs Sector & Market
| Metric | CTXR | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 2 | 8 | 19 |
| Target Upside | — | +1708.8% | +16.4% |
| P/E Ratio | -0.39 | 3.30 | 27.60 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $74M | $78M | $82M | 1 |
| 2027-09-30 | $131M | $144M | $157M | 1 |
| 2028-09-30 | $175M | $184M | $193M | 1 |
| 2029-09-30 | $198M | $209M | $219M | 1 |
| 2030-09-30 | $211M | $221M | $232M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $1.56 | $1.66 | $1.76 | 1 |
| 2027-09-30 | $2.61 | $2.79 | $2.97 | 1 |
| 2028-09-30 | $2.32 | $2.48 | $2.64 | 1 |
| 2029-09-30 | $2.65 | $2.83 | $3.01 | 1 |
| 2030-09-30 | $2.77 | $2.96 | $3.15 | 1 |
Frequently Asked Questions
What is the analyst consensus for CTXR?
The consensus among 2 analysts covering Citius Pharmaceuticals, Inc. (CTXR) is Buy with an average price target of N/A.
How many analysts cover CTXR?
2 analysts have issued ratings for Citius Pharmaceuticals, Inc. in the past 12 months.
Is CTXR a buy or sell right now?
Based on 2 analyst ratings, CTXR has a consensus rating of Buy (2.00/5) with a N/A upside to the consensus target of N/A.
What are the earnings estimates for CTXR?
Analysts estimate CTXR will report EPS of $1.66 for the period ending 2026-09-30, with revenue estimated at $78M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.